Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD-1 or anti PD-L1) compared with standard chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer (NSCLC).
Original language | English |
---|---|
Article number | CD012644 |
Number of pages | 14 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2017 |
Issue number | 4 |
DOIs | |
Publication status | Published - 26 Apr 2017 |